Smidler, Andrea L.
Marrogi, Eryney
Kauffman, Jamie
Paton, Douglas G.
Westervelt, Kathleen A.
Church, George M.
Esvelt, Kevin M.
Shaw, W. Robert
Catteruccia, Flaminia
Funding for this research was provided by:
NIH/NIAID (F31 AI120480-02, R01 AI104956)
Howard Hughes Medical Institute/Bill and Melinda Gates Foundation (OPP1158190)
Defense Advanced Research Projects Agency under the Safe Genes program
Burroughs Welcome Fund IRSA (1016432)
NIH (R00-DK102669-04)
HHMI
Article History
Received: 8 June 2023
Accepted: 13 February 2024
First Online: 19 February 2024
Competing interests
: J.K., E.M., K.A.W., D.P., W.R.S. and F.C. report no conflicts of interest. A.S. and K.E. hold a patent on the competing technology (Patent No. WO2015105928A1). A.S. is a co-filer on a patent application for a complementary technology (SD2022-357). For a complete list of G.C.’s financial interests, please visit arep.med.harvard.edu/gmc/tech.html.